The last study, by Arefan et al., identified that semi-quantitative features (tumour volume, mean peak enhancement of the tumour) from dynamic contrast-enhanced MRI could only moderately predict CD8+ TILs (validation AUC = 0.62, 95% CI: NA) [39]. This evidence concerns the gene CD8A and neoplasm.